Soma M R, Donetti E, Parolini C, Barberi L, Paoletti R, Fumagalli R, Catapano A L
Institute of Pharmacological Sciences, University of Milan, Italy.
J Cardiovasc Pharmacol. 1994;23 Suppl 5:S71-4. doi: 10.1097/00005344-199423005-00015.
The in vivo antiatherogenic activity of the calcium antagonist lacidipine was investigated in arterial hyperplasia induced by perivascular manipulation of hypercholesterolemic carotid rabbits. This was accomplished by positioning a hollow silastic collar around one carotid, which within a few days induces an atherosclerotic lesion (proliferative lesion) showing biochemical and morphologic changes similar to those of early human atherosclerosis: the contralateral carotid, with no collar, served as control in the same animal. The effect of lacidipine was also investigated in aortic atherosclerotic lesions (fatty lesions) induced by hypercholesterolemia mixed with either cholesterol (1%) and lacidipine (3 mg/kg/day) or cholesterol (1%) alone for 8 weeks. Hypercholesterolemic New Zealand White rabbits were fed daily a standard diet. Intimal hyperplasia was mechanically induced in one carotid artery of each rabbit 6 weeks after dietary and drug treatment started. Neointimal formation was followed by measuring by light microscopy the cross-sectional thickness of intimal (I) and medial (M) tissue of fixed arteries. In positive control animals receiving dietary cholesterol only (n = 10), by 14 d after collar positioning the process of intimal hyperplasia was significantly pronounced. The control arteries showed an I:M tissue ratio of 0.03 +/- 0.02, whereas in the carotid with collar the ratio was 0.56 +/- 0.11. In the animals receiving lacidipine, neointimal formation was significantly lower [I:M tissue ratio 0.32 +/- 0.1 (n = 10), about 60% of positive controls]. Measurement of the percent area of the aortic intima covered by plaques did not show significant differences between control and lacidipine-treated animals. These results suggest a direct antiatherosclerotic effect of lacidipine on proliferative lesions.
在高胆固醇血症颈动脉兔的血管周围操作诱导的动脉增生中,研究了钙拮抗剂拉西地平的体内抗动脉粥样硬化活性。这是通过在一条颈动脉周围放置一个中空的硅橡胶套环来实现的,在几天内会诱导出一个动脉粥样硬化病变(增殖性病变),其显示出与早期人类动脉粥样硬化相似的生化和形态学变化:对侧未放置套环的颈动脉作为同一动物的对照。还研究了拉西地平对高胆固醇血症与胆固醇(1%)和拉西地平(3毫克/千克/天)或仅胆固醇(1%)混合诱导8周的主动脉动脉粥样硬化病变(脂肪性病变)的影响。高胆固醇血症的新西兰白兔每天喂食标准饮食。在饮食和药物治疗开始6周后,对每只兔子的一条颈动脉进行机械诱导内膜增生。通过光学显微镜测量固定动脉内膜(I)和中膜(M)组织的横截面厚度来跟踪新生内膜的形成。在仅接受饮食胆固醇的阳性对照动物(n = 10)中,套环放置后14天,内膜增生过程明显显著。对照动脉的I:M组织比率为0.03±0.02,而放置套环的颈动脉中该比率为0.56±0.11。在接受拉西地平的动物中,新生内膜形成明显较低[I:M组织比率为0.32±0.1(n = 10),约为阳性对照的60%]。对斑块覆盖的主动脉内膜面积百分比的测量显示,对照动物和接受拉西地平治疗的动物之间没有显著差异。这些结果表明拉西地平对增殖性病变具有直接的抗动脉粥样硬化作用。